NCT06321627View on ClinicalTrials.gov

Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 14, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

HPV-Related Carcinoma

Interventions

RADIATION

Radiation therapy as curative treatment

Radiation therapy as curative treatment (exclusive, post-operative, with or without chemotherapy) for HPV-related squamous cell carcinomas of the oropharynx, uterine cervix, and anus

Trial Locations (1)

Unknown

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER

NCT06321627 - Radiosensitivity of HPV-related Tumors: Towards a Genomic Approach | Biotech Hunter | Biotech Hunter